Depression: biological and neuroendocrine aspects.

Area of Science:

• Neuroendocrinology
• Psychiatry
• Chronobiology

Background:

• Depressive disorders are associated with disruptions in biological rhythms and neuroendocrine system functioning.
• Hormonal imbalances are frequently observed in individuals with depression.

Purpose of the Study:

• To investigate the neuroendocrine abnormalities in depressive disorders.
• To determine if these abnormalities are reversible with treatment and if they can predict relapse.
• To differentiate neuroendocrine profiles between depression, schizophrenia, and secondary depression.

Main Methods:

• Assessment of the hypothalamic-pituitary-adrenal (HPA) axis, including dexamethasone suppression test.
• Evaluation of the thyrotropin-releasing hormone (TRH) test for thyroid-stimulating hormone (TSH) response.
• Measurement of growth hormone (GH) release during hypoglycemia.
• Analysis of gonadotropin levels and melatonin secretion patterns.
• Comparison of neuroendocrine markers in patients with major depression, schizophrenia, and secondary depression.

Main Results:

• Common hormonal abnormalities include decreased ACTH-cortisol axis suppressibility, subnormal TSH response to TRH, blunted GH release, attenuated gonadotropin production, and abnormal melatonin secretion.
• These neuroendocrine derangements are reversible with effective treatment for depression.
• Persistent abnormalities correlate with incomplete recovery and may predict early relapse.
• Neuroendocrine profiles in schizophrenia and secondary depression differ from those in primary depression.

Conclusions:

• Neuroendocrine abnormalities in depression appear to be state-dependent rather than trait-dependent, as they are reversible with treatment.
• The reversibility suggests these hormonal changes are epiphenomena of the primary depressive disorder.
• Distinct neurochemical alterations underlie schizophrenia and secondary depression compared to primary depressive disorders.